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A B S T R A C T
Background: Medication self-management is important for patients who are controlling diabetes. Achieving
medication self-management goals, may depend on treatment complexity and patients’ capacities such as health
literacy, knowledge and attitude.
Objectives: The aims of this study were to explore how patients with diabetes self-manage their medications, how
patients seek support when experiencing problems and how primary healthcare providers identify patients’
medication related problems and provide support.
Methods: Semi-structured interviews were conducted among patients with diabetes receiving primary care and
with their primary healthcare providers – GPs, nurses, pharmacists and technicians – between January and June
2017. A purposive sampling strategy was used to identify and select participants. An interview guide based on
the Cycle of Complexity model was developed. Interviews were audiotaped and transcribed verbatim.
Transcripts were coded with a combination of deductive and inductive codes. A thematic analysis was performed
to identify categories and themes in the data. Findings were compared with the Cycle of Complexity model.
Results: Twelve patients and 27 healthcare providers were included in the study. From the transcripts 95 codes,
6 categories and 2 major themes were extracted. Patients used practical solutions and gaining knowledge to
manage their medication. Their problems were often related to stress and concerns about using medications. A
trusted relationship with the healthcare provider was essential for patients to share problems and ask for sup-
port. Informal support was sought from family and peer-patients. Healthcare providers perceive problem
identification as challenging. They relied on patients coming forward, computer notifications, clinical para-
meters and gut-feeling. Healthcare providers were able to offer appropriate support if a medication management
problem was known.
Conclusion: Patients are confident of finding their way to manage their medications. However, sharing problems
with healthcare providers requires a trusted relationship. This is acknowledged by both patients and healthcare
providers.
Background
Self-management is an important element for patients to control
their diabetes. Self-management is an “individual's ability to manage
symptoms, treatment, physical and psychosocial consequences and life
style changes inherent in living with a chronic condition”.1 The extent
to which patients with diabetes are able to perform self-management
depends on treatment complexity, their health literacy, diabetes- and
medication-related knowledge and attitude.2–4 Treatment complexity in
patients with diabetes often comprises the complex treatment of dia-
betes itself and the therapy for comorbidities. Approximately 85% of all
patients with diabetes have at least one comorbidity and 25% have four
or more comorbidities.5–8 This leads to increased use of both primary
and hospital healthcare.7,9 Treatment complexity is also positively
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correlated with therapy non-adherence, risk for medication related
problems, and reduced patients' self-management capacities.10–18
Health literacy – one's ability to access, understand, appraise and apply
health information across the different aspects of healthcare – is related
to patients' self-management capacity and influences disease and
treatment awareness.19,20 Lower health literacy levels negatively affect
patients' self-management capacities as well as patients' low illness
perceptions.20,21 These factors could impact patients with diabetes to
have inadequate medication self-management and morbidity.
Patients with diabetes have problems with medication self-man-
agement.22 In addition to complex treatment regimens and the afore-
mentioned patient characteristics, self-management problems could be
associated with patients' dissatisfaction with therapy, drug related
problems, or decision making about how to use the prescribed
therapy.10–13,23,24 Whereas self-management in itself is dependent on a
patients' network and feeling of support from the environment.25 Pa-
tients with diabetes can obtain information from many sources about
prescribed therapy and medication management, including searching
the internet and approaching healthcare providers.22 Community
pharmacists are easily accessible and play an important role in im-
proving self-management and clinical outcomes and reducing medica-
tion related problems among patients with diabetes.26,27 Physicians and
nurses have demonstrated their added value in educating patients about
self-management to improve diabetes outcomes.28,29 Triggers for in-
formation seeking behaviour of patients and preferred sources of in-
formation for different kind of questions is lacking.22 Healthcare pro-
viders use many tools to identify medication related problems: clinical
decision support systems, professional judgement, current guidelines,
patient surveys, and computerized support systems. Though, the role of
communication between patients and healthcare providers is under-
served in identifying medication related problems.30–32 Some patients
experience time constraints and traditional, paternalistic attitudes
when approaching healthcare providers for information and consulta-
tion.33,34 It is unknown how these experiences influences patients’
choices and behaviour in case of medication related problems.
From the current literature it is unknown when, what and from
whom patients with diabetes seek support in case of medication man-
agement problems. Also little is known how primary healthcare pro-
viders consider support for different kinds of problems. The aims of this
study are to further explore how patients with diabetes self-manage
their medications, how they seek support when experiencing problems,
as well as to explore how primary healthcare providers identify medi-
cation related problems in patients with diabetes and how they support
this group of patients. All explorations are done according to the cycle
of complexity model.
Theoretical background
As discussed in the introduction, self-management of medication
and disease is influenced by many factors, including comorbidities,
network and social well-being. The cycle of complexity model is a
theoretical framework illustrating how these factors are related to each
other and how they can affect a patient's experience of health.35 The
cycle of complexity model (Fig. 1) considers aspects that are important
for patients with multiple chronic conditions. “Preferences and ex-
pectations” of the patient are the central focus point. The current study
focused on the four components closest to the patient's health, namely
acute shocks and medical events, workload, capacity and resilience and
access and utilization. These four themes were used to develop the topic
list for the interviews. Acute shocks and medical events include both
positive and negative events that might occur in a patient's life. In this
current study patients were asked about other medical conditions be-
sides their diabetes that might influence medication management. This
could either relate to themselves or a close relative. The workload refers
to all the effort a patient has to make to manage daily activities, in-
cluding their medical conditions. For example, how did they fit in
medication management into their daily life? Capacity and resilience
refers to all the abilities and resources a patient has to manage for their
medical conditions and assigned therapy. Do they experience any kind
of support from their environment? Access and utilization includes both
the physical and social distance to healthcare as experienced by pa-
tients. Can patients easily approach their healthcare providers if they
have any questions or problems? Changes in any of the components
could affect the experience of burden of treatment and the burden of
illness and could either increase or decrease a patient's medical com-
plexity.
The use of this model initiated a more holistic approach of medi-
cation management problems. The model was applied in the develop-
ment of the interview guide to prepare topics in the different aspects
presented in the model. Presentation of the results were guided by the
model to structure the participants’ responses. In the discussion, the
current findings were compared with the main topics presented in the
model and how they played a role among the participants. The use of
this model may have narrowed the scope of this study, though the ex-
ploratory nature of this study gave all participants the space to express
themselves fully.
Although data have been collected among all the different aspects
presented in the model, this manuscript focusses on workload, capacity
and resilience, and access and utilization.
Methods
Study design
Qualitative semi-structured interviews were conducted to explore
the aims of this study. Patient interviews took place at the patient's
home or – on patient's request – in a private consultation area in a GP
practice. Healthcare provider interviews took place at their workplace.
Study setting
All participants in the study were part of the primary healthcare
system in the Netherlands, either as healthcare provider – general
practitioner, nurse practitioner, community pharmacist or pharmacy
technician – or as patient treated in primary care.
In the Netherlands, where all citizens are assigned to one particular
general practice, diabetes care for patients with uncomplicated diabetes
type 2 is arranged through the general practice in diabetes care groups,
a group of healthcare providers together responsible for the chronic
diabetes care.36,37 According to protocol, patients have regular ap-
pointments with a nurse practitioner or diabetes nurse every three
months. The nurse discusses the patient's clinical parameters, general
well-being and asks about possible problems with life style adaptations
and medication use. Once a year patients with diabetes are seen by their
general practitioner for a more thorough check-up.38 Dutch community
pharmacies provide a wide variety of services to patients.39 Patients are
usually registered in one particular community pharmacy. Ambulatory
patients have the majority of their medications dispensed at their re-
gistered community pharmacy. Most pharmacies frequently request
additional clinical parameters from the general practice. Therefore,
pharmacy staff is able to accurately monitor a patient's medication,
provide patients with appropriate guidance and information about
medication use and build a sustainable relationship with the patient.
Sampling strategy
A purposive sampling strategy was used. Recruitment started with
pharmacists in different regions. Participating pharmacists were asked
for names of their general practitioners and nurse practitioners colla-
borations for snowball sampling. This led to the inclusion of a sample of
primary healthcare providers from different geographical regions, who
had different practice characteristics, and personal characteristics.
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Patients were recruited through primary healthcare providers and
basic Dutch language courses offered by local libraries. At the end of the
interview with the healthcare providers they were asked for eligible
patients in their practice. No specific patient cases were discussed with
the healthcare providers related to their own patients. Dutch speaking
patients with diabetes were sampled and purposively included patients
with at least one of the following characteristics: low literacy, low
health literacy, known diabetes medication related problems or con-
cerns, multi-morbidity or diabetes therapy adherence related problems.
Except for low literacy, patients meeting the inclusion criteria were
based on healthcare provider's professional judgement. The eligibility
criteria were discussed with the healthcare provider to assess their
understanding of the terms. Low literacy was assumed if patients were
enrolled in a basic language course for low literates. The language
courses focused mainly on low literate native Dutch speakers. Patients
approached through language courses were eligible if they were fa-
miliar with a diagnoses of diabetes.
Sampling continued until saturation was reached. Saturation was
assumed when no new answers or topics were identified in two con-
secutive interviews. Saturation was assessed for patients, GP staff
(general practitioners and nurse practitioners) and pharmacy staff
(pharmacists and pharmacy technicians) separately.
Instruments and data collection
An interview guide was used for conducting the interviews. This
guide was developed according to the cycle of complexity model for
multi-morbid patients.35 The interview guides are presented in Sup-
plementary file 1. Conducting the interviews was an iterative process,
new topics and answers arising from previous interviews were in-
troduced in upcoming interviews. New topics only emerged during the
first few interviews and could be discussed in a sufficient number of
interviews. All interviews were conducted by LvE. She had neither
personal nor professional relationships with the interviewees. Data
were collected between January and June 2017.
Data processing and analysis
All interviews were audiotaped and transcribed verbatim using the
software F4 Transkript. The transcripts were coded and analysed in
Atlas.ti 7.5.18. Coding was performed with a combination of deductive
and inductive codes. Deductive codes were derived from the topics used
in the interview guide and the inductive codes from the interviews it-
self. The coding was carried out in two steps. First more general and
broad codes were applied. Second, subcodes were added for nuancing
the results and to be able to perform a proper thematic analysis.40 All
codes are presented in Supplementary file 1. After the coding, a the-
matic analysis was performed according to the theory of Julie Green
et al.41 This theory describes a four steps approach to summarise data
from qualitative sources; (1) data immersion, (2) coding, (3) creating
categories and (4) identifying themes. The first author, LvE, coded all
the interviews. Coding was developed in agreement with HdG, KT and
LvD. A double check was performed for half of the interviews by HdG,
KT and LvD. Coded fragments to be included in the analyses were re-
viewed by KT and LvD. Any disagreements were solved by discussion.
Findings of the study were compared to the Cycle of Complexity model.
Ethical statement and privacy
The medical ethical committee of the University Medical Centre
Groningen in Groningen, the Netherlands determined that this research
does not have to comply with the Medical Research Involving Human
Subjects Act. The study has been registered in the University Medical
Centre Groningen Research Register with study number 201600659. All
participants in the study were informed prior to the interview and were
given the opportunity to ask questions and request for additional in-
formation. All participants signed informed consent on the day of the
interview. Data were stored on a secured server of the University of
Groningen and all research material was provided with a study ID. The
key to the study ID was electronically stored and secured with a pass-
word. Study data were only available to the primary researchers.
Fig. 1. Aspects addressed of Cycle of Complexity
Model.35 Reprinted by permission from Springer
Nature Customer Service Centre GmbH: Springer
Nature. Journal of General Internal Medicine. A
systematic review of conceptual frameworks of
medical complexity and new model development,
Zullig LL, Whitson HE, Hastings SN, Beadles C,
Kravchenko J, Akushevich I, Maciejewski ML, 2015.
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Results
Twelve patients were interviewed for this study, ranging from 52 to
85 years of age. Interviews lasted for 17 up to 70min (Table 1). Twenty-
seven healthcare providers were included; 11 pharmacists (PHA), 5
pharmacy technicians (TEC), 4 general practitioners (GP) and 7 nurse
practitioners (NUR) (Table 1). These interviews lasted for 21–56min
and were conducted in their workplace, with the exception of one nurse
interview (NUR007). Recruitment rates for patients and healthcare
providers were respectively 80% and 47%. We extracted 95 codes, six
categories and two major themes from the data. These themes were self-
management – including the categories; practical problems and con-
cerns about medicines, skills and knowledge and environmental influ-
ences – and accessibility of healthcare – including the categories;
communication, support and problem identification. Results of the
pharmacist and the technician were combined in this section because
their responses were comparable and patients often spoke about the
pharmacy in general without specifying with whom they had contact.
Self-management
Practical problems and concerns about medicines
Overall, patients reported coping well with the practical aspects of
medicine use. Taking medications was not highly influenced by the
number of medicines. Patients used different tools to assist themselves
in taking medicines at the right time: using a pillbox, storing medica-
tions in the place of use or setting an alarm on a mobile phone. Patients
reported that when they experienced stress – either work-related or due
to private matters – or when they had concerns about using medication
they had problems, including missing a dose, losing faith in therapy and
side effects. Medication related concerns varied from an overall nega-
tive attitude towards using medication at all, previously experienced
side effects or the perspective of having to use insulin in the future.
These factors – experienced stress and concerns about medication –
could be associated with either intentional or unintentional medication
non-adherence. Many patients reported that adherence was important
for good control of their diabetes, to avoid relapses in disease state and
was even sometimes driven by fear. Some patients also mentioned the
rewarding effects of good adherence, like improvement of their clinical
parameters and maintenance of a good quality of life. Though,
adherence remained also challenging because of different distractions
and disruptions in daily routines that could appear unexpectedly.
“And if, if you do not have the discipline of regularity, well then your
medicines won't be very effective. That's the difficulty of taking medi-
cines.” (Patient, Male, 67 yrs).
While patients reported few problems with practical issues, phar-
macy staff indicated they most often received questions from patients
with diabetes related to the practical barriers with regard to medication
use and controlling diabetes. Patients reached out to the pharmacy for
questions related to their blood glucose measurement device and
testing materials, how to take their medication, refill prescriptions and
medication management when loosing track of their therapy.
Sometimes patients presented questions regarding the side effects of
medication, especially at the start of a new therapy or when switching
to a different brand. Pharmacy staff also emphasized the negative effect
of experiencing side effects on patient's medication adherence.
General practitioners also noted the occurrence of side effects. Both
general practitioners and nurses described this as one of the main
medication related problems among patients with diabetes affecting
therapy adherence and clinical outcomes. Patients asked question in
their general practice related to their therapy in general (e.g. possible
changes in their medication). Patients also expressed concerns in the
general practice, especially when consulting the nurse practitioner.
Most concerns were related to initiating a new medication, having to
use insulin in the future, and the impact of diabetes and medication use
on daily life and their job.
“Often it's just practical questions; Do I take it before or after dinner?
What kind of side-effects can I expect? Those are the most common
questions.” (Technician, female, 30 yrs).
“Sometimes people already have pictured their own reality. And then
when you start explaining, you hear something like *pff..*, they sigh and
start to relax. Oh, ok, well it is not as bad as I had imagined.” (Nurse,
female, 56 yrs).
Skills and knowledge
Patients’ level of knowledge about diabetes and its treatment, and
interest in improving their knowledge varied. However, for some pa-
tients, interest in gaining knowledge was a dynamic process that
changed over time. After a period of acceptance patients usually de-
veloped a greater interest in medication management and increasing
their general knowledge about diabetes and its treatment. Patients
obtained information from leaflets, internet, and peers. Especially peers
could be a motivating factor for increasing knowledge because patients
did not want to be perceived as knowing less than their peers.
Increasing knowledge empowered patients to realize the importance of
appropriate therapy.
Pharmacy staff, general practitioners and nurse practitioners in-
dicated patients' inadequate knowledge about medication and diabetes
had an important impact on medication adherence and medication
management. This inadequate knowledge also influenced the level to
which patients were willing to accept information from healthcare
providers and to what extent they were willing to cooperate with
healthcare providers. A lack of knowledge impeded patients to under-
stand the relation between appropriate therapy and improving diabetes
outcomes. Furthermore, GPs and nurses indicated that concerns about
diabetes were often related to a lack of knowledge about, for example,
patients' fear of insulin therapy and the perception of severe compli-
cations. GPs and nurses primary concern was related to patients who
understood that they were failing therapy but were withdrawing
themselves from care. According to the GP staff, in some cases this
might be related to patients being afraid of the healthcare provider's
reaction to their failing therapy adherence.




Age 64.8 yrs (52–85)
Gender 50% female
Living situation
Alone 41.7%, (n= 5)
With partner 41.7%, (n= 5)
With partner and children 16.7%, (n= 2)
Education
Primary school 8.3%, (n=1)
Secondary school 50%, (n= 6)
Vocational training 16.7%, (n= 2)
Degree university of applied sciences 16.7%, (n= 2)
Degree research university 8.3%, (n=1)






Age 46.0 yrs (23–71)
Gender 66.7% female
Years of experience 19.6 yrs (3–49)
Duration interview 38.0min (21–56)
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was the influence of health literacy on patients' knowledge and how
they handled their diabetes care. Patients with limited health literacy
skills were not necessarily treated differently. When healthcare provi-
ders knew that patients had low health literacy, they would adapt in-
formation to meet the patient's literacy level. However, none of the
healthcare providers formally assesses health literacy levels among
their patients. Patients did not address their own health literacy levels.
“Of course, we have a couple of patients with whom it (the treatment
red.) really doesn't work. That's often a combination of unknowing and
not being able to understand.” (GP, female, 49 yrs).
Environmental influences
Only two patients briefly mentioned the influence of their en-
vironment on their diabetes management. Both discussed the im-
portance of understanding of diabetes at work. It is a patient's respon-
sibility to inform their employer and co-workers if they want them to
know something about the fact that they have diabetes and to enable
them to offer support.
Healthcare providers emphasized the importance of the influence of
patients' social environment on how patients handled their medication
management. Problems in their living situation or at work might cause
medication management not to be a main priority. Lifestyle habits like
smoking or an unhealthy diet were also hard to break through if pa-
tients did not feel supported by relatives. Nurse practitioners clarified a
patient's living situation. Sometimes a GP and occasionally pharmacy
staff would also address living situation. Whether or not patients were
open to share information depended on the nature of the underlying
problem and the quality of the relationship with the healthcare pro-
vider.
“Yeah, trust is very important, yeah, very important. Because, well, it's
(the medication red.) about something that keeps my body going. I mean,
if you don't have trust, it (talking to a healthcare provider red.) becomes
difficult.” (Patient, male, 56 yrs).
Accessibility of healthcare
Communication
Patients experienced communication with primary healthcare pro-
viders differently. Most patients mentioned the nurse practitioner to be
the first healthcare provider consulted in case of questions regarding
diabetes or medication. Patients reported that their relationship with
the nurse practitioner was the most familiar and that nurses were in-
volved in their healthcare and took time to listen. In comparison, asking
the GP placed a time burden on the patient. In the pharmacy, patients
reported experiencing little privacy and an emotional distance between
them and the pharmacy staff. Some patients indicated they felt phar-
macy staff was not so much concerned about nor involved in their ill-
ness. Patients were sometimes reluctant to discuss personal questions in
the pharmacy due to unpleasant experiences in the past. Though, for
less private matters and more general healthcare questions the phar-
macy was mentioned more frequently, mainly because of the accessi-
bility of the pharmacy. Questions were often related to refill prescrip-
tions, travelling with insulin and general health questions without
urgency. Once patients felt more familiar with the pharmacy staff and
the staff took time to answer questions adequately, patients were more
open to communication.
“Yes, I like it, I think it's good that you get to know them (pharmacy staff
red.). Also if you have questions – I also hear other people asking
questions and then they take the time to look it up. So, yeah, I think that's
very good, actually.”(Patient, female, 64 yrs).
All groups of healthcare providers reported the importance of being
aware of their communication with patients. Discussing sensitive topics
– like lifestyle and medication adherence – required adaptation of their
communication style to the patients' preferences. Adjusting commu-
nication styles was repeatedly reported by pharmacists and pharmacy
technicians and considered as very challenging. Especially when the
pharmacy staff had the feeling patients responded evasively. Pharmacy
staff indicated the importance of a good relationship with patients and
knowledge of a patient's living situation for adequate communication
between pharmacy staff and patients.
GPs and nurses emphasized the content of the communication.
Consultations with patients were dynamic processes and required active
involvement of both patient and healthcare provider. The healthcare
provider should provide a safe environment for patients to ask ques-
tions and discuss health related issues. The information provided by the
healthcare provider should answer the patient's question, but had to be
concise and not overloading the patient with too much information.
Regularly checking if the patient understood you benefitted both par-
ties. It gave the patient the opportunity to ask more questions and it
gave the healthcare provider the opportunity to give an additional ex-
planation if necessary.
“I always try to build my stories based on the questions patients ask me.
Because the sad thing is, it is chronic, it is never going away, but we also
don't have to arrange everything within a week.” (Nurse, female, 56 yrs).
“Well, you always try to explain things on the patient's level. Sometimes
even that is not enough and then at a certain point, you know you can
continue giving advice, but you have to be careful not to overload patients
with information or to correct them.” (Pharmacist, male, 29 yrs).
Support
Patients’ medication management benefitted from a supportive en-
vironment. Patients indicated that family members living together with
them were an important source of everyday support. Family members
acted as reminders as well as mental support, not only for the medi-
cation management but also for secondary needs like keeping up a
healthy lifestyle and looking up information. Patients living alone and
without family nearby felt alone in their day-to-day needs. Another
source of informal support were fellow patients. This peer support gave
patients the feeling they were not alone and they were for once not the
exception in a group.
“Yes, yes, yes, my husband worries about me, he worries a lot. He always
keeps an eye on me.” (Patient, female, 57 years).
“Well, tell me what you would like to know. And then he (husband) looks
it up for me, well and then I get it.” (Patient, female, 64 yrs).
Formal support from healthcare providers was mainly sought from
the nurse practitioner. Not only for medication related problems, but
also for psychosocial understanding. Patients had the feeling the nurse
practitioner was the most engaged in their well-being. The pharmacist,
technician and the GP had a less important role in this.
Healthcare providers reported to support patients with their medi-
cation related problems using three different main approaches. The first
way was practical support by means of personalized medication dis-
tribution systems, adapting the medication regimen to the patient's
schedule, medication refill services and instructions on how to use a
blood glucose measurement device. The second method was to offer
education about the effect of medication, the importance of adherence
and the relationship between medication use and lifestyle and the way
it affects a patient's health. Finally, healthcare providers reached out to
a patient's informal caregivers. Caregivers could disclose additional
information and could be an important channel to get information to a
patient. All three different methods were mentioned by the different
groups of healthcare providers. However, GPs and nurses had more
affinity with general diabetes advice, lifestyle adaptations and con-
tacting caregivers, whereas the pharmacy staff stayed closer to medi-
cation related advice and solving problems related to practical medi-
cation taking issues. They all highlighted the importance of tailoring
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the advice to a patient's needs. Also, they emphasized patients should
not be punished for mistakes made regarding their therapy. It was more
important to disclose the cause of the mistakes and to find an appro-
priate solution.
“It's always baby steps, little things. But people are very hesitant about it.
They think it's scary and they don't know where to begin. So then, I take
them by the hand and hope for the best.” (Nurse, female, 58 yrs).
Problem identification
For all healthcare providers part of the problem identification
among patients with diabetes was simply asking the patient about any
experienced problems or questions or if the patient introduced a pro-
blem or question without the healthcare provider having to ask for it.
Besides this direct way of problem identification, the different
healthcare providers indicated the use of indirect methods. The main
way for pharmacy staff to identify problems in patients with diabetes
was through notifications from the pharmacy computer system. This
system gave pop-ups if a patient came in too early or too late for a refill
prescription. Less frequently used methods were discussing the medi-
cation list if a patient picks up a medication overview, an ever growing
medication lists, patients who sounded confused, information provided
by the medication delivery driver and gut-feeling of the pharmacy staff.
The GP and nurse focused on identifying the underlying issue of an
observed problem. They used the observation to discuss the cause of the
problem with the patient. Triggers to start a discussion for identifying
the underlying problem were fluctuating clinical measurements, the
patient looking physically unwell, frequent visits to the GP practice and
also gut-feeling.
“If clinical parameters are not OK. If you see, well, the parameters are
fluctuating, complaints or not. If people are not looking too well. You can
see it in their faces.” (Nurse, female, 58 yrs).
Discussion
This research explored medication management in patients with
diabetes and the role of primary care providers. Patients' problems were
mainly related to concerns about therapy and a negative attitude to-
wards using medications, in addition to the previously reported causes
of medication management problems, patients' dissatisfaction with
therapy, drug related problems, and decision making about how to use
the prescribed therapy.10–13,23,24 To share problems, patients had to feel
comfortable with a healthcare provider. From a patient's perspective,
nurse practitioners were found to put the most effort in establishing a
good relationship with the patient, which can be expected from the
frequency of contact between nurse practitioners and patients when
acting according to the Dutch guidelines for diabetes mellitus in pri-
mary care.38,42 Patients perceived that pharmacy staff were the least
involved in patients' well-being. This might explain why pharmacy staff
found it difficult to sufficiently identify and address medication man-
agement problems among patients with diabetes. Communication and
empathizing was not only perceived as important by patients to es-
tablish a good relationship, it was also deemed important by healthcare
providers to identify medication management problems. Once a medi-
cation management problem was known to the healthcare provider and
accepted by the patient as such, all healthcare providers found them-
selves able to respond adequately and provide appropriate support.
Workload
Workload includes all factors influencing the effort one must take to
manage daily activities as was reported by Zullig et al., 2016.35 No
novelties were identified in our study that contribute to this part of the
cycle of complexity model. In our study, patients indicated that they
found themselves ways to implement medication use into their daily
routine. Most of the patients did not experience any problems with the
practical side of using medications, with the exception of the occur-
rence of distractions or unexpected disruptions of daily routines. Also
concerns and burden of side-effects were only mentioned by a minority
of the patients. For healthcare providers practical problems were one of
the main issues raised. An explanation for this might be that healthcare
providers have contact with many patients. This study did not explore
what proportion of patients experienced side effects and visited either
the pharmacy of GP practice.
Nurse practitioners reported the importance of job stress and family
on medication management. Increasing stress levels – either at work or
at home – have a negative influence on life style and medication
management. However, psychosocial work stress has not been reported
to have a negative influence on glycemic control directly.43
Capacity and resilience
Capacity and resilience include personal resources equipping pa-
tients to deal with medication management. The findings of the current
study agree with the description of the Cycle of Complexity model.35
Patients emphasized the importance of acceptance of the disease before
being able to increase knowledge and social support. This was ac-
knowledged by the pharmacy staff. Social support is an important
factor for developing self-management among patients with dia-
betes.44,45 Concerns patients had about having diabetes, the treatment
itself and medication use in general put a large burden on patients.
General practitioners and nurse practitioners recognized comparable
concerns in patients with diabetes. These concerns might influence
patients' medication adherence. Once concerns were identified by
healthcare providers, the cause could often be assigned to limited
knowledge – sometimes in combination with low health literacy skills.
This is confirmed by the studies of Fransen et al., 2015 and Ahola et al.,
2013.2,4 In the current study, it seemed that low health literacy skills
were associated with a lower willingness to accept information from
healthcare providers. This was previously reported by both Fransen
et al., 2015 and Heijmans et al., 2015.2,20 Especially older patients,
lower educated patients and patients with multi-morbidities are at
higher risk of low health literacy skills and as result of this might have
lower self-management capacities.20 Increasing patients’ knowledge has
a positive effect on their attitude towards medication use.28,46
Access and utilization
The current study contributes to the framework cycle of complexity
in the category ‘access and utilization’. In this category the framework
mainly takes into account the physical accessibility of healthcare fa-
cilities and the healthcare seeking behaviour of the patient.35 There is
no attention for the barriers perceived by patients when reaching out to
healthcare providers. Results from the current study demonstrate the
importance of adequate and appropriate communication skills of
healthcare providers for discussing medication related problems. The
attitude of the healthcare provider towards patients is crucial for pa-
tients to get the feeling they are welcome to address problems and ask
for advice, otherwise they feel limited in their access to their care
providers.
Communication between healthcare providers and patients about
medication related problems can be perceived as difficult. Especially if
patients do not address a problem themselves. A known problem in
both general practice and the community pharmacy.47–49 Even more
difficult is it to address sensitive topics like medication adherence. This
requires a certain level of empathy and communication skills of
healthcare providers and they need to take the time to have an open
discussion with patients. Patients want to be felt understood by
healthcare providers. Limited research has focused on communication
between patients and healthcare providers and the influence on pa-
tients' outcomes.50 Especially research about pharmacists’
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communication skills and the effect on therapy is lagging behind.51
However, the importance of good communication of healthcare provi-
ders has already been acknowledged.52–54
Strengths and limitations
This is the first study using a theoretical framework to explore
healthcare seeking behaviour of patients with diabetes in the event of
medication related problems. This framework provided guidance for a
comprehensive and holistic approach of the exploration of medication
related problems. So far studies have only focused on the type of
medication related problems and the causes of medication related
problems.10–13,24,33 Also, it provides in depth information about how
primary healthcare providers identify and respond to medication re-
lated problems in patients with diabetes.
This study has also several limitations. Firstly, the recruitment of
participants was challenging. Many healthcare providers indicated they
had no time for an interview, which explains the limited number of GPs
and pharmacy technicians included in the study. However, in combi-
nation with the interviews with pharmacists and nurse practitioners it
was possible to reach saturation of the data. Recruitment of vulnerable
patients was also difficult because most patients had to be approached
through healthcare providers. After the interview, healthcare providers
were asked to look for vulnerable patients with diabetes in their prac-
tice and to ask them if they would like to participate in the study. Since
there was no benefit for the healthcare providers in this, healthcare
providers had to be approached several times to hear back from them.
Secondly, ideally patient interviews were conducted first followed by
interviews with healthcare providers to get insight in the perceptions of
healthcare seeking and providing in the same situation. Results from
both parties on the same cases could have been even more com-
plementary. In the current study, interviews with healthcare providers
were followed by patient interviews. The included patients were not
necessarily linked to one of the interviewed healthcare providers.
Finally, the decision of reaching saturation of the data is arbitrary and
made in a pragmatic way. However, due to the exploratory nature of
this study, this seems a minor limitation.
Implications for practice
The results of this study show room for improvement in commu-
nication between patients with diabetes and primary care providers.
Especially the communication with patients with low health literacy
capacities deserves attention. The first step is to identify these patients
followed by offering appropriate support.55 Pharmacy staff should de-
velop skills for actively approaching patients to identify and discuss
possible problems, because they now mainly rely on medication ad-
herence pop-ups from the pharmacy computer system. General diabetes
care in the general practice could even be more shifted towards nurse
practitioners to give general practitioners more time to spend on
complex consultations. Not only communication skills are important
but also attitude and providing privacy and understanding. Further-
more, close collaboration between general practitioners, nurse practi-
tioners, pharmacists and pharmacy technicians can have a positive ef-
fect on patient outcome.56 Though, also patients might contribute to
more efficient consultations. In the Dutch system, GP appointments are
made in advance through a GP's assistant. If patients provide sufficient
information, assistants could perform better triage and make a better
estimation of the length of the consultation necessary. Further research
should focus on enabling patients on where to go with medication re-
lated questions, referral to appropriate healthcare providers and edu-
cating healthcare providers on communication skills to further increase
patients' health.
Conclusion
Patients' problems and concerns were often related to a lack of
knowledge or insufficient knowledge about medications and diabetes
and might have a negative influence on patients' medication self-man-
agement. Patients experiencing medication related problems found
support from relatives, peers and healthcare providers. The preferred
healthcare provider was the nurse practitioner, because of the familiar
and trusted relationship. Healthcare providers by healthcare providers
relied on patients coming forward with a problem, computer notifica-
tions, clinical parameters and gut-feeling. All healthcare providers were
able to offer support by means of practical support, education and in-
volving caregivers in a patient's care. However, establishing a trusted
relationship and sufficiently addressing of problems seemed to be the
limiting factor in offering appropriate support.
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